Literature DB >> 28693248

Exon 7 splicing variant of estrogen receptor α is associated with pathological invasiveness in smoking-independent lung adenocarcinoma.

Ayumi Suzuki1, Katsuhiro Okuda1, Motoki Yano1, Risa Oda1, Tadashi Sakane1, Osamu Kawano1, Hiroshi Haneda1, Satoru Moriyama1, Makoto Nakanishi2, Ryoichi Nakanishi1.   

Abstract

Patients with smoking-independent lung cancer mainly consist of females, yet the molecular background of this epidemiological feature, other than epidermal growth factor receptor (EGFR) mutation, remains unclear. Several studies have revealed the association between female hormone-associated factors and the prognosis of lung cancer, however the data remain inconsistent. The present study focused on the expression of estrogen receptor (ER)α in order to elucidate this association in smoking-independent lung cancer. Immunohistochemistry staining (IHC) of aromatase, ERα and ERβ was performed against formalin-treated tissues from 38 patients who had never-smoked who underwent complete surgical resection between 2012 and 2013. Among them, adequate RNA of the tumor and adjacent normal lung cancer was extracted from 31 matching deep frozen samples. Considering the IHC results, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to measure the expression level of 2 different exons of ERα, exon 6 and exon 7, which are part of the ligand binding domain of ERα, using the Taqman gene expression assay. Extra-nuclear expression of ERα using IHC demonstrated a statistically significant association with pathological invasiveness. RT-qPCR results exhibited a decreased expression of ERα exon 7 in invasive tumor tissues, compared with their adjacent normal tissues. This is consistent with the findings of previous in vitro studies indicating that extra-nuclear ERα were exon 7 splicing variants. No difference was observed in ERα exon 7 expression between normal and tumor tissues in non-invasive lung cancer tissues. When considering the EGFR mutation status, EGFR wild-type lung cancers exhibited decreased ERα exon 7 expression levels compared with EGFR mutated lung cancers. Extra-nuclear expression of ERα, which may represent exon 7 splicing variants of ERα, showed statistical association with pathological invasiveness in smoking-independent lung cancer. The post-translational splicing mechanism of ERα may be involved in the acquired invasiveness of smoking independent lung cancer.

Entities:  

Keywords:  estrogen receptor; invasiveness; lung adenocarcinoma; non-smoker; splicing variant

Year:  2017        PMID: 28693248      PMCID: PMC5494717          DOI: 10.3892/ol.2017.6216

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies.

Authors:  Ann G Schwartz; Roberta M Ray; Michele L Cote; Judith Abrams; Robert J Sokol; Susan L Hendrix; Chu Chen; Rowan T Chlebowski; F Allan Hubbell; Charles Kooperberg; JoAnn E Manson; Mary Jo O'Sullivan; Thomas Rohan; Marcia L Stefanick; Jean Wactawski-Wende; Heather Wakelee; Michael S Simon
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609

Review 3.  Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.

Authors:  Burkhard Brandt; Sönke Meyer-Staeckling; Hartmut Schmidt; Konstantin Agelopoulos; Horst Buerger
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

4.  Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex.

Authors:  Ann G Schwartz; Geoffrey M Prysak; Valerie Murphy; Fulvio Lonardo; Harvey Pass; Jan Schwartz; Sam Brooks
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

Review 5.  Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations.

Authors:  Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2014-08

6.  Association between hormone receptor expression and epidermal growth factor receptor mutation in patients operated on for non-small cell lung cancer.

Authors:  Hai-bo Sun; Yan Zheng; Wei Ou; Qin Fang; Pan Li; Xiong Ye; Bin-bin Zhang; Hua Yang; Si-yu Wang
Journal:  Ann Thorac Surg       Date:  2011-05       Impact factor: 4.330

7.  Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations.

Authors:  Mikihiro Kohno; Tatsuro Okamoto; Kenichi Suda; Mototsugu Shimokawa; Hirokazu Kitahara; Shinichiro Shimamatsu; Hideyuki Konishi; Tsukihisa Yoshida; Mitsuhiro Takenoyama; Tokujiro Yano; Yoshihiko Maehara
Journal:  Clin Cancer Res       Date:  2014-05-06       Impact factor: 12.531

8.  Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.

Authors:  Hiromichi Niikawa; Takashi Suzuki; Yasuhiro Miki; Satoshi Suzuki; Shuji Nagasaki; Junichi Akahira; Seijiro Honma; Dean B Evans; Shin-Ichi Hayashi; Takashi Kondo; Hironobu Sasano
Journal:  Clin Cancer Res       Date:  2008-06-25       Impact factor: 12.531

9.  Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.

Authors:  Keiko Abe; Yasuhiro Miki; Katsuhiko Ono; Miki Mori; Hideaki Kakinuma; Yuki Kou; Nobutaka Kudo; Masashi Koguchi; Hiromichi Niikawa; Satoshi Suzuki; Dean B Evans; Shunichi Sugawara; Takashi Suzuki; Hironobu Sasano
Journal:  Hum Pathol       Date:  2009-10-01       Impact factor: 3.466

10.  HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer.

Authors:  Marc Hirschfeld; Yi Qin Ouyang; Markus Jaeger; Thalia Erbes; Marzenna Orlowska-Volk; Axel Zur Hausen; Elmar Stickeler
Journal:  BMC Cancer       Date:  2015-02-27       Impact factor: 4.430

View more
  2 in total

Review 1.  Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.

Authors:  María José García-Barrado; Enrique J Blanco; María Carmen Iglesias-Osma; Marta Carretero-Hernández; Leonardo Catalano-Iniesta; Virginia Sanchez-Robledo; Manuel Carretero; Julio Joaquín Herrero; Sixto Carrero; José Carretero
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

Review 2.  Mechanisms for estrogen receptor expression in human cancer.

Authors:  Hui Hua; Hongying Zhang; Qingbin Kong; Yangfu Jiang
Journal:  Exp Hematol Oncol       Date:  2018-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.